Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Demarest

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Archives of Biochemistry and Biophysics|January 11, 2012
Secretion from bacterial versus mammalian cells yields a recombinant scFv with variable folding propertiesMichelle C Vendel, Michael Favis, William B Snyder, et al.
Mabs|February 13, 2010
Neutralization of Clostridium difficile toxin A using antibody combinationsStephen J Demarest, Mangala Hariharan, Marikka Elia, et al.
Proteins|December 18, 2008
Conserved amino acid networks involved in antibody variable domain interactionsNorman Wang, William F Smith, Brian R Miller, et al.
Mabs|January 23, 2015
Protein design of IgG/TCR chimeras for the co-expression of Fab-like moieties within bispecific antibodiesXiufeng Wu, Arlene J Sereno, Flora Huang, et al.
The Journal of Biological Chemistry|August 15, 2006
An intermediate pH unfolding transition abrogates the ability of IgE to interact with its high affinity receptor FcepsilonRIalphaStephen J Demarest, Jennifer Hopp, Julie Chung, et al.
Protein Engineering, Design & Selection : PEDS|May 5, 2006
Engineering stability into Escherichia coli secreted Fabs leads to increased functional expressionStephen J Demarest, Gang Chen, Bruce E Kimmel, et al.
Protein Engineering, Design & Selection : PEDS|May 12, 2010
Stability engineering of scFvs for the development of bispecific and multivalent antibodiesBrian R Miller, Stephen J Demarest, Alexey Lugovskoy, et al.
Molecular Cancer Therapeutics|August 19, 2010
Combination of two insulin-like growth factor-I receptor inhibitory antibodies targeting distinct epitopes leads to an enhanced antitumor responseJianying Dong, Stephen J Demarest, Arlene Sereno, et al.
Structure (London, England : 1993)|March 22, 2016
Computationally Designed Bispecific Antibodies using Negative State RepertoiresAndrew Leaver-Fay, Karen J Froning, Shane Atwell, et al.
Mabs|March 17, 2015
Fab-based bispecific antibody formats with robust biophysical properties and biological activityXiufeng Wu, Arlene J Sereno, Flora Huang, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Archives of Biochemistry and Biophysics|January 11, 2012
Secretion from bacterial versus mammalian cells yields a recombinant scFv with variable folding propertiesMichelle C Vendel, Michael Favis, William B Snyder, et al.
Mabs|February 13, 2010
Neutralization of Clostridium difficile toxin A using antibody combinationsStephen J Demarest, Mangala Hariharan, Marikka Elia, et al.
Proteins|December 18, 2008
Conserved amino acid networks involved in antibody variable domain interactionsNorman Wang, William F Smith, Brian R Miller, et al.
Mabs|January 23, 2015
Protein design of IgG/TCR chimeras for the co-expression of Fab-like moieties within bispecific antibodiesXiufeng Wu, Arlene J Sereno, Flora Huang, et al.
The Journal of Biological Chemistry|August 15, 2006
An intermediate pH unfolding transition abrogates the ability of IgE to interact with its high affinity receptor FcepsilonRIalphaStephen J Demarest, Jennifer Hopp, Julie Chung, et al.
Protein Engineering, Design & Selection : PEDS|May 5, 2006
Engineering stability into Escherichia coli secreted Fabs leads to increased functional expressionStephen J Demarest, Gang Chen, Bruce E Kimmel, et al.
Protein Engineering, Design & Selection : PEDS|May 12, 2010
Stability engineering of scFvs for the development of bispecific and multivalent antibodiesBrian R Miller, Stephen J Demarest, Alexey Lugovskoy, et al.
Molecular Cancer Therapeutics|August 19, 2010
Combination of two insulin-like growth factor-I receptor inhibitory antibodies targeting distinct epitopes leads to an enhanced antitumor responseJianying Dong, Stephen J Demarest, Arlene Sereno, et al.
Structure (London, England : 1993)|March 22, 2016
Computationally Designed Bispecific Antibodies using Negative State RepertoiresAndrew Leaver-Fay, Karen J Froning, Shane Atwell, et al.
Mabs|March 17, 2015
Fab-based bispecific antibody formats with robust biophysical properties and biological activityXiufeng Wu, Arlene J Sereno, Flora Huang, et al.
Pageof 4